BETA


2018/2775(RSP) Resolution on use of cannabis for medicinal purposes

Progress: Procedure completed

RoleCommitteeRapporteurShadows
Lead ENVI ŠUICA Dubravka (icon: PPE PPE), BALAS Guillaume (icon: S&D S&D), KRUPA Urszula (icon: ECR ECR), BEARDER Catherine (icon: ALDE ALDE), HÄUSLING Martin (icon: Verts/ALE Verts/ALE), PEDICINI Piernicola (icon: EFDD EFDD)
Lead committee dossier:

Events

2019/07/17
   EC - Commission response to text adopted in plenary
Documents
2019/02/13
   EP - Results of vote in Parliament
2019/02/13
   EP - Decision by Parliament
Details

The European Parliament adopted a resolution tabled by the Committee on the Environment, Public Health and Food Safety on the use of cannabis for medicinal purposes. The resolution notes that several cannabinoids which make up the cannabis plant, can help reduce certain symptoms affecting patients – such as chronic pain, inflammation or bacterial infections – and can stimulate bone growth. There is evidence that cannabis or cannabinoids may be effective in increasing appetite and decreasing weight loss associated with HIV/AIDS, in alleviating symptoms of mental disorders such as psychosis or Tourette syndrome, and in alleviating symptoms of epilepsy, as well as Alzheimer’s, arthritis, asthma, cancer, and Crohn’s disease.

Parliament pointed out that EU Member States differ widely in their approach to legislation on cannabis for medical purposes, such as on the maximum allowed levels of THC and CBD concentrations, which can lead to difficulties for countries applying a more prudent approach. Whilst the policy landscape for medical cannabis is evolving in the EU and worldwide, misunderstandings still exist even among national administrations regarding the different uses of cannabis, with the legalisation on cannabis for recreational use often being confused with the need to provide legal access to cannabis for medical purposes to all patients in need.

The resolution called on the Commission and the Member States to address the regulatory, financial and cultural barriers that weigh on scientific research into the use of cannabis for medicinal purposes and on research into cannabis in general. It considered that research on the potential benefits of medicines derived from cannabis has been underfunded and should be properly addressed under the forthcoming Ninth Framework Programme, with a view to exploring, inter alia, the possible uses of THC, CBD and other cannabinoids for medical treatment, including lessons drawn from the experience of off-label prescribing of cannabis.

Member States were asked to allow doctors to make free use of their professional judgement in prescribing regulatory-approved cannabis-based medicines to patients with relevant conditions, and to allow pharmacists to lawfully honour those prescriptions.

Parliament invited the Commission to:

- work with national authorities to provide a legal definition of medical cannabis, and to draw a clear distinction between cannabis-based medicines approved by the EMA or other regulatory agencies, medical cannabis not supported by clinical trials, and other applications of cannabis (e.g. recreational or industrial) ;

- develop a comprehensive strategy to ensure the highest standards for independent research, development, authorisation, marketing and pharmacovigilance and to avoid the abuse of products derived from cannabis;

- establish a network which would bring together the EMA, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), responsible national authorities and patient organisations, civil society, social partners, consumer organisations, healthcare professionals and NGOs, along with other relevant stakeholders, in order to ensure effective implementation of the strategy for cannabis-based medicines;

- work with Member States to improve equal access to cannabis-based medicines and to ensure that, where allowed, medicines which are effective in treating specific conditions are covered by health insurance schemes in the same way as other medicines.

- work with Member States to ensure that safe and controlled cannabis used for medicinal purposes can only be in the form of cannabis-derived products that have gone through clinical trials, regulatory assessment and approval;

- ensure that research into, and use of, medical cannabis in the Union does not in any way favour criminal drugs networks or lead to their expansion;

The resolution called on Member States to:

- reconsider their relevant legislation on the use of cannabis-based medicines when scientific research proves that the same positive effect cannot be achieved by using ordinary medicines that do not have addictive effects;

- provide a safe and equal choice for patients between different types of cannabis-based medicine, while ensuring that patients are accompanied by specialised medical professionals during their treatment;

- ensure sufficient availability of cannabis-based medicines that cater for actual needs, either by means of production in accordance with their national medical standards or perhaps through imports that comply with their national requirements for cannabis-based medicines;

- provide medical professionals with proper medical training and to encourage increased knowledge on medical cannabis based on independent and wide-ranging research.

Documents
2019/02/13
   EP - End of procedure in Parliament
2019/02/12
   EP - Debate in Parliament
2019/02/11
   EP - Oral question/interpellation by Parliament
Documents
2019/02/11
   EP - Motion for a resolution
Documents
2018/08/17
   EP - Amendments tabled in committee
Documents
2018/04/11
   EP - ŠUICA Dubravka (PPE) appointed as rapporteur in ENVI
2018/04/11
   EP - BALAS Guillaume (S&D) appointed as rapporteur in ENVI
2018/04/11
   EP - KRUPA Urszula (ECR) appointed as rapporteur in ENVI
2018/04/11
   EP - BEARDER Catherine (ALDE) appointed as rapporteur in ENVI
2018/04/11
   EP - HÄUSLING Martin (Verts/ALE) appointed as rapporteur in ENVI
2018/04/11
   EP - PEDICINI Piernicola (EFDD) appointed as rapporteur in ENVI

Documents

Votes

B8-0071/2019 - Am 12/1 13/02/2019 17:30:26.000 #

2019/02/13 Outcome: -: 306, +: 274, 0: 27
IT FR DE ES MT LT EL ?? CY NL LU AT EE CZ SI FI HR IE PT LV BE RO GB SK HU DK BG SE PL
Total
55
63
78
45
5
8
13
1
2
24
6
18
4
19
7
11
10
8
17
6
17
24
57
12
10
12
14
13
46
icon: S&D S&D
147

Malta S&D

2

Lithuania S&D

1

Cyprus S&D

For (1)

1

Netherlands S&D

3

Luxembourg S&D

For (1)

1

Czechia S&D

3

Slovenia S&D

For (1)

1

Croatia S&D

For (1)

1

Ireland S&D

For (1)

1

Latvia S&D

1
3

Bulgaria S&D

2
icon: Verts/ALE Verts/ALE
44

Italy Verts/ALE

For (1)

1

Lithuania Verts/ALE

For (1)

1

Netherlands Verts/ALE

2

Luxembourg Verts/ALE

For (1)

1

Austria Verts/ALE

3

Estonia Verts/ALE

Against (1)

1

Slovenia Verts/ALE

For (1)

1

Croatia Verts/ALE

For (1)

1

Latvia Verts/ALE

1

Belgium Verts/ALE

2

United Kingdom Verts/ALE

4

Hungary Verts/ALE

2

Denmark Verts/ALE

For (1)

1

Sweden Verts/ALE

3
icon: GUE/NGL GUE/NGL
41

Italy GUE/NGL

2

Cyprus GUE/NGL

Abstain (1)

1

Netherlands GUE/NGL

For (1)

3

Finland GUE/NGL

For (1)

1

Ireland GUE/NGL

2

Portugal GUE/NGL

For (1)

4

United Kingdom GUE/NGL

1

Denmark GUE/NGL

Abstain (1)

1
icon: ALDE ALDE
57

Germany ALDE

Against (1)

3

Lithuania ALDE

2

Luxembourg ALDE

For (1)

1

Austria ALDE

For (1)

1

Estonia ALDE

2

Czechia ALDE

4

Slovenia ALDE

For (1)

1

Finland ALDE

Abstain (1)

4

Croatia ALDE

2

Ireland ALDE

Against (1)

1

Portugal ALDE

1

Romania ALDE

For (1)

1

United Kingdom ALDE

1

Denmark ALDE

For (1)

Against (1)

2

Bulgaria ALDE

Abstain (1)

4

Sweden ALDE

Against (1)

Abstain (1)

2
icon: EFDD EFDD
36

Germany EFDD

Against (1)

1

Lithuania EFDD

For (1)

1

Czechia EFDD

Against (1)

1

Poland EFDD

1
icon: ENF ENF
33

Germany ENF

Against (1)

1

Netherlands ENF

3

Belgium ENF

Against (1)

1

United Kingdom ENF

3

Poland ENF

2
icon: NI NI
15

France NI

For (1)

Abstain (1)

2

Germany NI

Against (1)

1

NI

For (1)

1

United Kingdom NI

Against (2)

2

Hungary NI

Against (1)

1

Denmark NI

Against (1)

1
icon: ECR ECR
59

Lithuania ECR

Against (1)

1

Greece ECR

Against (1)

1

Netherlands ECR

2

Czechia ECR

2

Finland ECR

Against (1)

1

Croatia ECR

Against (1)

1

Latvia ECR

Against (1)

1

Belgium ECR

3

Romania ECR

Against (1)

1

Bulgaria ECR

Against (1)

1
icon: PPE PPE
173

Malta PPE

Against (1)

3

Lithuania PPE

2

Greece PPE

Against (1)

1

Luxembourg PPE

3

Estonia PPE

Against (1)

1
4

Belgium PPE

3

United Kingdom PPE

2

Denmark PPE

Against (1)

1

B8-0071/2019 - Am 12/2 13/02/2019 17:30:38.000 #

2019/02/13 Outcome: -: 427, +: 149, 0: 26
FR ?? CY EE LT FI LU IE NL EL LV MT ES CZ HR SI PT DK HU BE IT BG AT SE SK RO GB DE PL
Total
64
1
2
4
8
10
6
8
23
13
5
5
44
19
10
7
16
12
10
17
56
13
18
13
12
25
57
76
46
icon: GUE/NGL GUE/NGL
39

Cyprus GUE/NGL

Abstain (1)

1

Finland GUE/NGL

For (1)

1

Ireland GUE/NGL

Against (1)

2

Netherlands GUE/NGL

3

Czechia GUE/NGL

3

Denmark GUE/NGL

For (1)

1

Italy GUE/NGL

2

United Kingdom GUE/NGL

Against (1)

1
icon: EFDD EFDD
36

Lithuania EFDD

For (1)

1

Czechia EFDD

Abstain (1)

1

Germany EFDD

Against (1)

1

Poland EFDD

1
icon: ALDE ALDE
58

Estonia ALDE

2

Lithuania ALDE

2

Finland ALDE

Abstain (1)

4

Luxembourg ALDE

For (1)

1

Ireland ALDE

Against (1)

1

Czechia ALDE

4

Croatia ALDE

2

Slovenia ALDE

Abstain (1)

1

Portugal ALDE

1

Denmark ALDE

For (1)

Against (1)

2

Bulgaria ALDE

Abstain (1)

4

Austria ALDE

For (1)

1

Sweden ALDE

Against (1)

Abstain (1)

2

Romania ALDE

For (1)

1

United Kingdom ALDE

1

Germany ALDE

Against (1)

3
icon: ENF ENF
33

Netherlands ENF

3

Belgium ENF

Against (1)

1

United Kingdom ENF

3

Germany ENF

Against (1)

1

Poland ENF

2
icon: Verts/ALE Verts/ALE
43

France Verts/ALE

Against (1)

6

Estonia Verts/ALE

Against (1)

1

Lithuania Verts/ALE

Against (1)

1

Luxembourg Verts/ALE

Against (1)

1

Netherlands Verts/ALE

2

Croatia Verts/ALE

Against (1)

1

Slovenia Verts/ALE

Against (1)

1

Denmark Verts/ALE

Against (1)

1

Hungary Verts/ALE

2

Belgium Verts/ALE

2

Italy Verts/ALE

Against (1)

1

Austria Verts/ALE

Against (1)

3

Sweden Verts/ALE

3

United Kingdom Verts/ALE

Against (2)

4
icon: NI NI
15

France NI

For (1)

Against (1)

2

NI

For (1)

1

Denmark NI

Against (1)

1

Hungary NI

Against (1)

1

United Kingdom NI

Against (2)

2

Germany NI

Against (1)

1
icon: ECR ECR
59

Lithuania ECR

Against (1)

1

Finland ECR

Against (1)

1

Netherlands ECR

2

Greece ECR

Against (1)

1

Latvia ECR

Against (1)

1

Czechia ECR

2

Croatia ECR

Against (1)

1

Belgium ECR

3

Bulgaria ECR

Against (1)

1

Romania ECR

Against (1)

1
icon: S&D S&D
148

Cyprus S&D

For (1)

1

Lithuania S&D

1

Finland S&D

Against (1)

2

Luxembourg S&D

Against (1)

1

Ireland S&D

For (1)

1

Netherlands S&D

3

Latvia S&D

Against (1)

1

Malta S&D

Against (2)

2

Czechia S&D

For (1)

3

Croatia S&D

Against (1)

1

Slovenia S&D

Against (1)

1
3

Belgium S&D

3

Bulgaria S&D

Against (1)

1
3
icon: PPE PPE
169

Estonia PPE

Against (1)

1

Lithuania PPE

2

Finland PPE

2

Luxembourg PPE

3

Greece PPE

Against (1)

1
4

Denmark PPE

Against (1)

1

Belgium PPE

3

United Kingdom PPE

2

B8-0071/2019 - Am 14S 13/02/2019 17:31:57.000 #

2019/02/13 Outcome: -: 319, +: 268, 0: 18
IT DE GB NL LT CY CZ EE ?? LU AT ES MT BE EL PT SI LV RO HR IE FI HU SK DK BG SE FR PL
Total
57
79
55
23
8
2
19
3
1
6
18
44
5
18
12
17
7
6
25
10
8
11
9
11
12
13
13
65
46
icon: S&D S&D
146

Netherlands S&D

3

Lithuania S&D

1

Cyprus S&D

For (1)

1

Czechia S&D

3

Luxembourg S&D

For (1)

1

Malta S&D

2

Greece S&D

2

Slovenia S&D

For (1)

1

Latvia S&D

1

Croatia S&D

For (1)

1

Ireland S&D

For (1)

1
3

Bulgaria S&D

For (1)

1
icon: Verts/ALE Verts/ALE
43

Italy Verts/ALE

For (1)

1

United Kingdom Verts/ALE

4

Netherlands Verts/ALE

2

Lithuania Verts/ALE

For (1)

1

Luxembourg Verts/ALE

For (1)

1

Austria Verts/ALE

3

Belgium Verts/ALE

2

Slovenia Verts/ALE

For (1)

1

Latvia Verts/ALE

1

Croatia Verts/ALE

For (1)

1

Hungary Verts/ALE

1

Denmark Verts/ALE

Against (1)

1

Sweden Verts/ALE

3
icon: EFDD EFDD
35

Germany EFDD

For (1)

1

Lithuania EFDD

For (1)

1

Czechia EFDD

For (1)

1

Poland EFDD

1
icon: GUE/NGL GUE/NGL
40

Italy GUE/NGL

2

United Kingdom GUE/NGL

Against (1)

1

Netherlands GUE/NGL

For (1)

3

Cyprus GUE/NGL

1

Portugal GUE/NGL

For (1)

4

Ireland GUE/NGL

Against (1)

2

Finland GUE/NGL

For (1)

1

Denmark GUE/NGL

For (1)

1
icon: ALDE ALDE
59

Germany ALDE

3

United Kingdom ALDE

1

Lithuania ALDE

2

Czechia ALDE

4

Estonia ALDE

2

Luxembourg ALDE

For (1)

1

Austria ALDE

For (1)

1

Portugal ALDE

1

Slovenia ALDE

Abstain (1)

1

Romania ALDE

For (1)

1

Croatia ALDE

For (1)

Against (1)

2

Ireland ALDE

Against (1)

1

Finland ALDE

Abstain (1)

4

Denmark ALDE

For (1)

Against (1)

2

Sweden ALDE

Against (1)

Abstain (1)

2
icon: NI NI
15

Germany NI

For (1)

1

United Kingdom NI

Against (2)

2

NI

For (1)

1

Hungary NI

For (1)

1

Denmark NI

Against (1)

1

France NI

2
icon: ENF ENF
33

Germany ENF

Against (1)

1

United Kingdom ENF

3

Netherlands ENF

Against (1)

3

Belgium ENF

Against (1)

1
2
icon: ECR ECR
60

Netherlands ECR

2

Lithuania ECR

Against (1)

1

Czechia ECR

2

Belgium ECR

3

Greece ECR

Against (1)

1

Latvia ECR

Against (1)

1

Romania ECR

Against (1)

1

Croatia ECR

Against (1)

1

Finland ECR

Against (1)

1

Bulgaria ECR

Against (1)

1
icon: PPE PPE
172

United Kingdom PPE

2

Lithuania PPE

2

Estonia PPE

Against (1)

1

Luxembourg PPE

3

Belgium PPE

3
2
4

Denmark PPE

Against (1)

1

B8-0071/2019 - Am 11 13/02/2019 17:33:48.000 #

2019/02/13 Outcome: -: 359, +: 211, 0: 32
FR EE CY LT ?? CZ FI BE LU SI IT IE NL DK MT HR LV EL PT ES HU AT SE SK RO BG GB DE PL
Total
65
4
2
8
1
19
11
18
6
7
57
8
23
11
5
10
6
13
16
45
10
17
13
12
25
13
56
74
45
icon: Verts/ALE Verts/ALE
45

Estonia Verts/ALE

For (1)

1

Lithuania Verts/ALE

For (1)

1

Belgium Verts/ALE

2

Luxembourg Verts/ALE

For (1)

1

Slovenia Verts/ALE

For (1)

1

Italy Verts/ALE

For (1)

1

Netherlands Verts/ALE

2

Denmark Verts/ALE

For (1)

1

Croatia Verts/ALE

For (1)

1

Latvia Verts/ALE

1

Hungary Verts/ALE

2

Austria Verts/ALE

3

Sweden Verts/ALE

3

United Kingdom Verts/ALE

4
icon: GUE/NGL GUE/NGL
41

Cyprus GUE/NGL

1

Finland GUE/NGL

For (1)

1

Italy GUE/NGL

2

Ireland GUE/NGL

2

Netherlands GUE/NGL

For (1)

3

Denmark GUE/NGL

For (1)

1

Portugal GUE/NGL

4

United Kingdom GUE/NGL

1
icon: ALDE ALDE
57

Estonia ALDE

2

Lithuania ALDE

2

Czechia ALDE

4

Luxembourg ALDE

For (1)

1

Slovenia ALDE

For (1)

1

Ireland ALDE

For (1)

1

Denmark ALDE

For (1)

Against (1)

2

Croatia ALDE

2

Portugal ALDE

1

Austria ALDE

For (1)

1

Sweden ALDE

2

Romania ALDE

For (1)

1

United Kingdom ALDE

1

Germany ALDE

2
icon: EFDD EFDD
34

Lithuania EFDD

Abstain (1)

1

Czechia EFDD

Against (1)

1

Poland EFDD

1
icon: ENF ENF
33

Belgium ENF

Against (1)

1

Netherlands ENF

3

United Kingdom ENF

3

Germany ENF

Against (1)

1
2
icon: NI NI
15

France NI

For (1)

Against (1)

2

NI

For (1)

1

Denmark NI

1

Hungary NI

Against (1)

1

United Kingdom NI

Against (2)

2

Germany NI

For (1)

1
icon: S&D S&D
144

Cyprus S&D

For (1)

1

Lithuania S&D

1

Czechia S&D

For (1)

3

Finland S&D

2

Belgium S&D

3

Luxembourg S&D

Abstain (1)

1

Slovenia S&D

For (1)

1

Ireland S&D

Against (1)

1

Netherlands S&D

For (1)

Against (2)

3

Denmark S&D

2

Malta S&D

For (1)

Against (1)

2

Croatia S&D

Against (1)

1

Latvia S&D

Against (1)

1

Greece S&D

2

Slovakia S&D

For (1)

3

Bulgaria S&D

Against (1)

1
icon: ECR ECR
59

Lithuania ECR

1

Czechia ECR

2

Finland ECR

Against (1)

1

Belgium ECR

3

Netherlands ECR

2

Croatia ECR

Against (1)

1

Latvia ECR

Against (1)

1

Greece ECR

Against (1)

1

Romania ECR

Against (1)

1

Bulgaria ECR

Against (1)

1
icon: PPE PPE
172

Estonia PPE

Against (1)

1

Lithuania PPE

2

Finland PPE

For (1)

3

Belgium PPE

For (1)

Against (2)

3

Luxembourg PPE

3
4

Denmark PPE

Against (1)

1
2

United Kingdom PPE

2
AmendmentsDossier
84 2018/2775(RSP)
2018/08/17 ENVI 84 amendments...
source: 625.379

History

(these mark the time of scraping, not the official date of the change)

committees/0/rapporteur/4
name
TORRES MARTÍNEZ Estefanía
date
2018-04-11T00:00:00
group
European United Left - Nordic Green Left
abbr
GUE/NGL
docs/0/docs/0/url
https://www.europarl.europa.eu/doceo/document/ENVI-AM-625379_EN.html
events/0/docs
  • url: https://www.europarl.europa.eu/doceo/document/CRE-8-2019-02-12-TOC_EN.html title: Debate in Parliament
docs/0/docs/0/url
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE625.379
docs/2/docs/0/url
Old
http://www.europarl.europa.eu/doceo/document/B-8-2019-0071_EN.html
New
https://www.europarl.europa.eu/doceo/document/B-8-2019-0071_EN.html
events/0/docs
  • url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20190212&type=CRE title: Debate in Parliament
events/2
date
2019-02-13T00:00:00
type
Decision by Parliament
body
EP
docs
url: https://www.europarl.europa.eu/doceo/document/TA-8-2019-0113_EN.html title: T8-0113/2019
summary
events/2
date
2019-02-13T00:00:00
type
Decision by Parliament, 1st reading/single reading
body
EP
docs
url: http://www.europarl.europa.eu/doceo/document/TA-8-2019-0113_EN.html title: T8-0113/2019
summary
committees/0
type
Responsible Committee
body
EP
committee_full
Environment, Public Health and Food Safety
committee
ENVI
associated
False
rapporteur
committees/0
type
Responsible Committee
body
EP
committee_full
Environment, Public Health and Food Safety
committee
ENVI
associated
False
rapporteur
docs/2/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B8-2019-0071&language=EN
New
http://www.europarl.europa.eu/doceo/document/B-8-2019-0071_EN.html
docs/3/body
EC
events/2/docs/0/url
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2019-0113
New
http://www.europarl.europa.eu/doceo/document/TA-8-2019-0113_EN.html
committees/0
type
Responsible Committee
body
EP
committee_full
Environment, Public Health and Food Safety
committee
ENVI
associated
False
rapporteur
committees/0
type
Responsible Committee
body
EP
committee_full
Environment, Public Health and Food Safety
committee
ENVI
associated
False
date
rapporteur
docs/3
date
2019-07-17T00:00:00
docs
url: /oeil/spdoc.do?i=32201&j=0&l=en title: SP(2019)327
type
Commission response to text adopted in plenary
events/1
date
2019-02-13T00:00:00
type
Results of vote in Parliament
body
EP
docs
url: https://oeil.secure.europarl.europa.eu/oeil/popups/sda.do?id=32201&l=en title: Results of vote in Parliament
commission
  • body: EC dg: Health and Food Safety commissioner: ANDRIUKAITIS Vytenis Povilas
committees
  • type: Responsible Committee body: EP committee_full: Environment, Public Health and Food Safety committee: ENVI associated: False date: 2018-04-11T00:00:00 2018-04-11T00:00:00 2018-04-11T00:00:00 2018-04-11T00:00:00 2018-04-11T00:00:00 2018-04-11T00:00:00 2018-04-11T00:00:00 rapporteur: name: ŠUICA Professor Dubravka group: European People's Party (Christian Democrats) abbr: PPE name: BALAS Guillaume group: Progressive Alliance of Socialists and Democrats abbr: S&D name: KRUPA Urszula group: European Conservatives and Reformists abbr: ECR name: BEARDER Catherine group: Alliance of Liberals and Democrats for Europe abbr: ALDE name: TORRES MARTÍNEZ Estefanía group: European United Left - Nordic Green Left abbr: GUE/NGL name: HÄUSLING Martin group: Greens/European Free Alliance abbr: Verts/ALE name: PEDICINI Piernicola group: Europe of Freedom and Direct Democracy abbr: EFDD
docs
  • date: 2018-08-17T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE625.379 title: PE625.379 type: Amendments tabled in committee body: EP
  • date: 2019-02-11T00:00:00 docs: title: B8-0001/2019 type: Oral question/interpellation by Parliament body: EP
  • date: 2019-02-11T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=MOTION&reference=B8-2019-0071&language=EN title: B8-0071/2019 type: Motion for a resolution body: EP
events
  • date: 2019-02-12T00:00:00 type: Debate in Parliament body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?secondRef=TOC&language=EN&reference=20190212&type=CRE title: Debate in Parliament
  • date: 2019-02-13T00:00:00 type: Decision by Parliament, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2019-0113 title: T8-0113/2019 summary: The European Parliament adopted a resolution tabled by the Committee on the Environment, Public Health and Food Safety on the use of cannabis for medicinal purposes. The resolution notes that several cannabinoids which make up the cannabis plant, can help reduce certain symptoms affecting patients – such as chronic pain, inflammation or bacterial infections – and can stimulate bone growth. There is evidence that cannabis or cannabinoids may be effective in increasing appetite and decreasing weight loss associated with HIV/AIDS, in alleviating symptoms of mental disorders such as psychosis or Tourette syndrome, and in alleviating symptoms of epilepsy, as well as Alzheimer’s, arthritis, asthma, cancer, and Crohn’s disease. Parliament pointed out that EU Member States differ widely in their approach to legislation on cannabis for medical purposes, such as on the maximum allowed levels of THC and CBD concentrations, which can lead to difficulties for countries applying a more prudent approach. Whilst the policy landscape for medical cannabis is evolving in the EU and worldwide, misunderstandings still exist even among national administrations regarding the different uses of cannabis, with the legalisation on cannabis for recreational use often being confused with the need to provide legal access to cannabis for medical purposes to all patients in need. The resolution called on the Commission and the Member States to address the regulatory, financial and cultural barriers that weigh on scientific research into the use of cannabis for medicinal purposes and on research into cannabis in general. It considered that research on the potential benefits of medicines derived from cannabis has been underfunded and should be properly addressed under the forthcoming Ninth Framework Programme, with a view to exploring, inter alia, the possible uses of THC, CBD and other cannabinoids for medical treatment, including lessons drawn from the experience of off-label prescribing of cannabis. Member States were asked to allow doctors to make free use of their professional judgement in prescribing regulatory-approved cannabis-based medicines to patients with relevant conditions, and to allow pharmacists to lawfully honour those prescriptions. Parliament invited the Commission to: - work with national authorities to provide a legal definition of medical cannabis, and to draw a clear distinction between cannabis-based medicines approved by the EMA or other regulatory agencies, medical cannabis not supported by clinical trials, and other applications of cannabis (e.g. recreational or industrial) ; - develop a comprehensive strategy to ensure the highest standards for independent research, development, authorisation, marketing and pharmacovigilance and to avoid the abuse of products derived from cannabis; - establish a network which would bring together the EMA, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), responsible national authorities and patient organisations, civil society, social partners, consumer organisations, healthcare professionals and NGOs, along with other relevant stakeholders, in order to ensure effective implementation of the strategy for cannabis-based medicines; - work with Member States to improve equal access to cannabis-based medicines and to ensure that, where allowed, medicines which are effective in treating specific conditions are covered by health insurance schemes in the same way as other medicines. - work with Member States to ensure that safe and controlled cannabis used for medicinal purposes can only be in the form of cannabis-derived products that have gone through clinical trials, regulatory assessment and approval; - ensure that research into, and use of, medical cannabis in the Union does not in any way favour criminal drugs networks or lead to their expansion; The resolution called on Member States to: - reconsider their relevant legislation on the use of cannabis-based medicines when scientific research proves that the same positive effect cannot be achieved by using ordinary medicines that do not have addictive effects; - provide a safe and equal choice for patients between different types of cannabis-based medicine, while ensuring that patients are accompanied by specialised medical professionals during their treatment; - ensure sufficient availability of cannabis-based medicines that cater for actual needs, either by means of production in accordance with their national medical standards or perhaps through imports that comply with their national requirements for cannabis-based medicines; - provide medical professionals with proper medical training and to encourage increased knowledge on medical cannabis based on independent and wide-ranging research.
  • date: 2019-02-13T00:00:00 type: End of procedure in Parliament body: EP
procedure
reference
2018/2775(RSP)
title
Resolution on use of cannabis for medicinal purposes
subject
type
RSP - Resolutions on topical subjects
subtype
Debate or resolution on oral question/interpellation
stage_reached
Procedure completed
dossier_of_the_committee
ENVI/8/12756